Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer - Wikidata - wikimedia - TriplyDB

Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer

Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer

http://www.wikidata.org/entity/Q35032491

about

Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy Signaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated Macrophages Tumor-infiltrating dendritic cells in cancer pathogenesis Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy Tumor infiltrating lymphocytes in ovarian cancer Phenotypic T cell exhaustion in a murine model of bacterial infection in the setting of pre-existing malignancy Targeted immune therapy of ovarian cancer Regulatory dendritic cells: there is more than just immune activation Orchestration of angiogenesis by immune cells Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease Melanoma-infiltrating dendritic cells: Limitations and opportunities of mouse models Pathological mobilization and activities of dendritic cells in tumor-bearing hosts: challenges and opportunities for immunotherapy of cancer Combinatorial PD-1 blockade and CD137 activation has therapeutic efficacy in murine cancer models and synergizes with cisplatin Natural IgM Switches the Function of Lipopolysaccharide-Activated Murine Bone Marrow-Derived Dendritic Cells to a Regulatory Dendritic Cell That Suppresses Innate Inflammation The expression and clinical relevance of PD-1, PD-L1, and TP63 in patients with diffuse large B-cell lymphoma PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma.The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer Accumulation of memory precursor CD8 T cells in regressing tumors following combination therapy with vaccine and anti-PD-1 antibody.Murine lung cancer induces generalized T-cell exhaustion.Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer.Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer.PD-1 Blunts the Function of Ovarian Tumor-Infiltrating Dendritic Cells by Inactivating NF-κB IL-27 induces the expression of IDO and PD-L1 in human cancer cells.PD-1 expression on dendritic cells suppresses CD8(+) T cell function and antitumor immunity Role of dendritic cells in the regulation of antitumor immunity Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.Immunotherapy: shifting the balance of cell-mediated immunity and suppression in human prostate cancer.Immune checkpoint blockade reveals the stimulatory capacity of tumor-associated CD103(+) dendritic cells in late-stage ovarian cancer.Aiming to immune elimination of ovarian cancer stem cells Stimulation through CD40 and TLR-4 Is an Effective Host Directed Therapy against Mycobacterium tuberculosis.Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model Therapeutic PD-1 pathway blockade augments with other modalities of immunotherapy T-cell function to prevent immune decline in ovarian cancer Ovarian tumor ascites CD14+ cells suppress dendritic cell-activated CD4+ T-cell responses through IL-10 secretion and indoleamine 2,3-dioxygenase.Tumor associated regulatory dendritic cells.Dendritic cells and their role in tumor immunosurveillance.Dendritic cell immunotherapy in ovarian cancer.Tumor-altered dendritic cell function: implications for anti-tumor immunity.

P2860

Q26765459-185FFAB8-3D8B-4CD3-9D6F-F527FC6356B0 Q26774345-80B82907-4FF8-4547-AC6B-05AEE29A59E0 Q26783748-4592D25F-DE33-480F-B33A-8FE40CEBEE9C Q26861633-E47FEB2B-D83D-4000-9BF0-2C6AE834C7FB Q26996829-55F04F25-54B8-4292-8ECD-71321DC7EE59 Q27021570-1B20DB00-7422-4F0C-8B91-9F8E0268DD21 Q27021878-7FBA829E-0640-49FD-8422-BFA6D4096639 Q27346770-045A4D58-C1C1-4032-88C5-8F626236C6C3 Q28082828-97BF9D80-D85F-4681-94AE-2269A6FC1EEB Q28388235-DE9EA88D-6FEE-4608-B51C-474C94571415 Q28389236-BEF18F34-99E6-4BA9-BF93-70EFD1542CD9 Q28391826-64582F51-8A71-434C-A1FD-76BA3FC544CE Q28392156-2E575D6F-0272-48FE-8D4D-B30BBB22F18B Q28392626-E69C2288-3103-49B4-B3E6-8CE9ABF86982 Q28537820-D0F1AA90-9DAD-4999-BA5A-A2CBE09719BB Q30278437-79816773-171C-49F6-BC26-D33AD04B82F0 Q33597192-E8794174-7E50-4163-AA04-E2E20A26B474 Q33648598-C6E668B4-E6C3-4BAE-986C-444F70DACD64 Q33659166-9BD121F7-5DF0-4457-9C82-9B636FBDB9EB Q35036388-6C53D3AE-9287-4D4B-A5F7-0ECC30ED7822 Q35562860-EEACC045-67C6-4F78-8914-30124A8C9B5E Q36021163-8D557938-3DCB-4039-8076-204E02CF9E8E Q36267621-657162EF-432B-483F-8E1B-F85AF2AE8BE0 Q36295211-04D71F1A-84FD-4CF2-A3A8-127F8DC0B9DF Q36471523-0C77D68F-3F58-4BE2-8DB0-2D7328F87B18 Q36685395-3D27F8CC-5744-4047-BF7C-1AE9F622BBB9 Q36821174-92A89208-CCBA-47F6-901F-71CC50E49907 Q36845842-949A903A-9A8D-44E6-8862-153D70A41B83 Q36941194-1FBF9CDA-87DF-465C-85C2-0840F0334824 Q37017085-EE36F56B-5FB3-4197-B391-BFA62C86A9F2 Q37224568-215F3A4C-D89A-4B75-A8D3-5DA5E270DE04 Q37266548-1F2BC7BE-6EC4-47DA-8862-BE6F8C73AF6E Q37284865-08F3105A-E7FC-477F-B708-DCF4297A7C8C Q37355822-998A9BE8-319A-4DE9-8AA2-8E35BD668BD2 Q37365673-411FD10A-8FC9-4AC0-B441-109C608ACFAA Q37637888-99505977-80B7-4CB9-B250-F705AE24B6D0 Q37993359-F659922D-62FE-41BF-B545-04AC6308907D Q38021625-B58656B7-6A12-49F8-B1CD-6C9D906B1278 Q38069183-59F124AB-BFC9-413D-A148-5D4E8969BA3C Q38123166-8D1454E8-66D2-4979-83FB-58D7FC46E7B2

P2860

Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer

http://www.wikidata.org/entity/Q35032491

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Tumor-infiltrating programmed ...... suppression in ovarian cancer

@ast

Tumor-infiltrating programmed ...... suppression in ovarian cancer

@en

type

label

Tumor-infiltrating programmed ...... suppression in ovarian cancer

@ast

Tumor-infiltrating programmed ...... suppression in ovarian cancer

@en

prefLabel

Tumor-infiltrating programmed ...... suppression in ovarian cancer

@ast

Tumor-infiltrating programmed ...... suppression in ovarian cancer

@en

P1433

Q35032491-C19CCDE6-1234-42DA-86F3-3AB8216BE317

P1476

Q35032491-D4D759DA-710F-4F8F-9070-E2CA7C095D9D

P2093

Q35032491-18FFF1A8-C85C-49DB-B1BB-0F848896286B

Q35032491-3DD761F6-FD7C-4416-8776-729EAACF716C

Q35032491-43C806E2-EA6F-4D6E-B355-B672EDAF7EC3

Q35032491-620F6789-0D52-4294-9D1B-A0E17973D084

Q35032491-7D29F4D3-F28C-4FD0-8F2C-4502493381D8

Q35032491-7D551483-0332-430F-BF9D-0830AA687131

Q35032491-92F5A6D9-1E5B-4DF0-9AF1-DC3114D846F9

Q35032491-B923BCA0-1B74-4C3F-9733-861A01C967D7

Q35032491-E87EBC46-E134-46AA-9F91-83D14CB65CC4

P2860

Q35032491-0073D6AB-726E-46BD-94B4-EF36CCAD559D

Q35032491-019659D2-4F17-4733-B1C7-D9E47B531778

Q35032491-032BB9E7-9DD2-41A5-86E4-2A6CCEF21DF9

Q35032491-0C72B1A3-0D03-4A37-B4EA-A22B446314B7

Q35032491-0DC7177A-D13C-4C96-8916-41E4F8488026

Q35032491-131CC00E-8A21-4D12-9D0C-ED90DA153A24

Q35032491-1BC95518-11DB-43C6-9625-6B2EA1E0F8A0

Q35032491-1C4AD02E-88B7-498B-9928-DD7B93E433E6

Q35032491-22B10F6D-7074-4B3E-ABE1-5E00FBEFC271

Q35032491-2AF3DF8B-63A4-4E5D-957C-834DBF10C0EB

P304

Q35032491-D7404BC8-B264-4E20-92CC-6F8389C5A7B0

P31

Q35032491-28DC0E1A-F92A-49C7-977A-16226822BA85

P356

Q35032491-3B096B1B-2D71-495B-BD1D-94C92654423B

P407

Q35032491-6A2BEE89-79E3-4F2E-9629-6C7C662CB36D

P433

Q35032491-B1FCABB9-DEE6-4955-92AA-8ECCF16F5AE8

P478

Q35032491-2395382B-62C7-4E6B-99D8-98039E027245

P577

Q35032491-242B86B1-6B82-461B-8E8F-2A75D366111F

P5875

Q35032491-6F5589A1-4F97-45D3-A7AA-FB299E2F8715

P698

Q35032491-2A29C24F-30E1-44C3-AEBA-C3BC7B5D4E71

P921

Q35032491-FCC756F8-E94D-4638-A7D5-31430C124BA2

P932

Q35032491-45A46AD0-05C2-415F-80F1-C7959CF3CFA6

P356

JIMMUNOL.1100274

P1433

Journal of Immunology

P1476

Tumor-infiltrating programmed ...... suppression in ovarian cancer

@en

P2093

Courtney L Erskine

http://www.w3.org/2001/XMLSchema#string

Ellen L Goode

http://www.w3.org/2001/XMLSchema#string

Haidong Dong

http://www.w3.org/2001/XMLSchema#string

James Krempski

http://www.w3.org/2001/XMLSchema#string

Keith L Knutson

http://www.w3.org/2001/XMLSchema#string

Kimberly R Kalli

http://www.w3.org/2001/XMLSchema#string

Lavakumar Karyampudi

http://www.w3.org/2001/XMLSchema#string

Lynn Hartmann

http://www.w3.org/2001/XMLSchema#string

Marshall D Behrens

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-10 and the interleukin-10 receptor

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

Myeloid-derived suppressor cells: linking inflammation and cancer

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

PD-1 and its ligands in tolerance and immunity

Molecular cloning of a C-type lectin superfamily protein differentially expressed by CD8alpha(-) splenic dendritic cells

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.

P304

6905-6913

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1100274

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

186

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51106733

http://www.w3.org/2001/XMLSchema#string

P698

21551365

http://www.w3.org/2001/XMLSchema#string

P921

P932

3110549

http://www.w3.org/2001/XMLSchema#string